RecruitingNCT05865691

Role of Coagulation, Inflammation and Vessels in Chronic Liver Disease


Sponsor

Assistance Publique - Hôpitaux de Paris

Enrollment

360 participants

Start Date

Sep 7, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

Chronic liver diseases represent a major public health problem and are responsible for more than 150,000 deaths in Europe each year. These diseases are accompanied by symptoms that profoundly alter the quality of life and mainly affect people of working age, leading to a major economic impact. Coagulation disorders, inflammation and vascular alterations are associated with chronic liver diseases but their role in the onset and/or progression of liver diseases is still not fully understood. A better understanding of chronic liver diseases and in particular of the factors that play a role in the onset and progression of these diseases would improve patient management and therefore have a positive impact on individuals, but also on the healthcare system and the economy.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying biomarker assay for people with chronic liver diseases and coagulation. The study is currently recruiting participants at 1 location.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERbiomarker assay

blood sample on the day of inclusion


Locations(1)

Beaujon Hospital

Clichy, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05865691


Related Trials